IHL — Incannex Healthcare Income Statement
0.000.00%
Last trade - 00:00HealthcareSpeculativeMicro Cap
- AU$65.07m
- AU$31.87m
- AU$1.38m
Annual income statement for Incannex Healthcare, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
R2019 June 30th | 2020 June 30th | R2021 June 30th | 2022 June 30th | 2023 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0.002 | 0.822 | 1.97 | 0.789 | 1.38 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Total Operating Expenses | 1.34 | 4.75 | 13.3 | 15.7 | 21.4 |
| Operating Profit | -1.34 | -3.93 | -11.4 | -14.9 | -20 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -1.43 | -3.93 | -11.4 | -14.9 | -20 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -1.43 | -3.93 | -11.4 | -14.9 | -20 |
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -2.72 | -4.7 | -11.4 | -14.9 | -20 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -2.72 | -4.7 | -11.4 | -14.9 | -20 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.003 | -0.006 | -0.012 | -0.013 | -0.013 |